Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection

More than a year after the start of the pandemic, COVID-19 remains a global health emergency. Although the immune response against SARS-CoV-2 has been extensively studied, some points remain controversial. One is the role of antibodies in viral clearance and modulation of disease severity. While pas...

Descripción completa

Detalles Bibliográficos
Autores principales: Choteau, Mathilde, Scohy, Anaïs, Messe, Stéphane, Luyckx, Mathieu, Dechamps, Mélanie, Montiel, Virginie, Yombi, Jean Cyr, Gruson, Damien, Limaye, Nisha, Michiels, Thomas, Dumoutier, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827092/
https://www.ncbi.nlm.nih.gov/pubmed/35136139
http://dx.doi.org/10.1038/s41598-022-06038-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827092/
https://www.ncbi.nlm.nih.gov/pubmed/35136139
http://dx.doi.org/10.1038/s41598-022-06038-5

Ejemplares similares